Skip to content
Open access

A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma

Sep 2026 · Blood Cancer Journal · Vol 16 · 0 citations · 19 references
Medicine

Abstract

(GPRC5D) is a leading immunotherapy target in multiple myeloma (MM), with diverse GPRC5D-targeting agents — including T-cell engagers (TCE), antibody – drug conjugates

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.